Facial Injectable Market
Facial Injectable Market - Global Industry Assessment & Forecast
#
Pages:
148
Base Year:
2022
Jun - 2022
Format:
Report Code:
VMR-1630
Segments Covered
By
Product Collagen, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Polymer Fillers
-
By
Application Aesthetics, Therapeutics
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 4.37 Billion |
 Revenue 2030:
|
USD 8.82 Billion |
 Revenue CAGR
(2023 - 2030): |
9.20% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Facial Injectable Market Segment Analysis
- Facial Injectable Product Outlook (Revenue, USD Million, 2018 - 2030)
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- Facial Injectable Application Outlook (Revenue, USD Million, 2018 - 2030)
- Aesthetics
- Therapeutics
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
-
North America Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- U.S.
- U.S. Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- U.S. Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- U.S. Facial Injectable Market, by Product
- Canada
- Canada Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- Canada Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- Canada Facial Injectable Market, by Product
-
Mexico
- Mexico Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- Mexico Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- Mexico Facial Injectable Market, by Product
-
North America Facial Injectable Market, by Product
- Europe
-
Europe Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
-
Europe Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- U. K.
- U.K. Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- U.K. Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- U.K. Facial Injectable Market, by Product
- France
- France Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- France Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- France Facial Injectable Market, by Product
-
Germany
- Germany Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- Germany Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- Germany Facial Injectable Market, by Product
-
Italy
- Italy Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- Italy Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- Italy Facial Injectable Market, by Product
-
Spain
- Spain Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- Spain Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- Spain Facial Injectable Market, by Product
-
Rest of Europe
- Rest of Europe Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- Rest of Europe Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- Rest of Europe Facial Injectable Market, by Product
-
Europe Facial Injectable Market, by Product
- Asia Pacific
-
Asia Pacific Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
-
Asia Pacific Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- China
- China Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- China Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- China Facial Injectable Market, by Product
- Japan
- Japan Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- Japan Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- Japan Facial Injectable Market, by Product
-
Germany
- Germany Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- Germany Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- Germany Facial Injectable Market, by Product
-
India
- India Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- India Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- India Facial Injectable Market, by Product
-
South Korea
- South Korea Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- South Korea Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- South Korea Facial Injectable Market, by Product
-
South East Asia
- South East Asia Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- South East Asia Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- South East Asia Facial Injectable Market, by Product
-
Rest of Asia Pacific
- Rest of Asia Pacific Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- Rest of Asia Pacific Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- Rest of Asia Pacific Facial Injectable Market, by Product
-
Asia Pacific Facial Injectable Market, by Product
- Latin America
-
Latin America Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
-
Latin America Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- Brazil
- Brazil Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- Brazil Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- Brazil Facial Injectable Market, by Product
- Argentina
- Argentina Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- Argentina Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- Argentina Facial Injectable Market, by Product
-
Rest of Latin America
- Rest of Latin America Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- Rest of Latin America Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- Rest of Latin America Facial Injectable Market, by Product
-
Latin America Facial Injectable Market, by Product
- Middle East & Africa
-
Middle East & Africa Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
-
Middle East & Africa Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- GCC Countries
- GCC Countries Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- GCC Countries Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- GCC Countries Facial Injectable Market, by Product
- South Africa
- South Africa Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- South Africa Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- South Africa Facial Injectable Market, by Product
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Facial Injectable Market, by Product
- Collagen
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Polymer Fillers
- Rest of Middle East & Africa Facial Injectable Market, by Application
- Aesthetics
- Therapeutics
- Rest of Middle East & Africa Facial Injectable Market, by Product
-
Middle East & Africa Facial Injectable Market, by Product
- North America
Vantage Market
Research | 06-Jun-2022
FAQ
Frequently Asked Question
What is the global demand for Facial Injectable in terms of revenue?
-
The global Facial Injectable valued at USD 4.37 Billion in 2022 and is expected to reach USD 8.82 Billion in 2030 growing at a CAGR of 9.20%.
Which are the prominent players in the market?
-
The prominent players in the market are Ipsen, Merz Pharma, Suneva Medical Inc., Medytox Inc., Sinclair Pharma, Bloomage BioTechnology Corporation Limited, Anika Therapeutics Inc., Prollenium Medical Technologies, Galderma, Allergan Inc..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 9.20% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Facial Injectable include
- Rising Demand for Facial Injectables to Enhance Aesthetic Beauty
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Facial Injectable in 2022.
